Package Leaflet: Information for the Patient
Axitinib Teva 1 mg film-coated tablets EFG
Axitinib Teva 5 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
This medicine contains the active substance axitinib. Axitinib reduces the blood supply to the tumor and reduces the growth of cancer.
Axitinib is indicated for the treatment of advanced kidney cancer (advanced renal cell carcinoma) in adults, when other medicines (called sunitinib or cytokines) are not able to slow down the progression of the disease.
If you have any questions about how this medicine works or why you have been prescribed it, ask your doctor.
Do not take Axitinib Teva:
If you are allergic to axitinib or any of the other ingredients of this medicine (listed in section 6).
If you think you may be allergic, talk to your doctor.
Warnings and precautions
Talk to your doctor or nurse before taking Axitinib Teva:
Axitinib may increase your blood pressure. It is important that you have your blood pressure checked before you start taking this medicine and periodically during treatment. If you have high blood pressure (hypertension), you may be treated with medicines that lower your blood pressure. Your doctor should make sure that you have your blood pressure under control before starting treatment with axitinib and during treatment with this medicine.
Axitinib may cause thyroid problems. Contact your doctor if you feel tired more easily, feel colder than other people, or your voice becomes deeper while taking this medicine. Before treatment with axitinib, your thyroid function should be checked and periodically while you are taking it. If your thyroid gland does not produce enough thyroid hormone, you may be treated with thyroid hormone replacement before or during treatment with this medicine.
Call the emergency service immediately and contact your doctor if you have symptoms such as chest pain or pressure, pain in your arms, back, neck, or jaw, shortness of breath, numbness or weakness on one side of your body, speech problems, headache, changes in vision, or dizziness while taking this medicine.
Axitinib may increase the risk of bleeding. Tell your doctor if you have bleeding, cough up blood or bloody sputum while taking this medicine.
Axitinib may increase the risk of developing a stomach ulcer or intestinal ulcer or the formation of fistulas (abnormal tube-like passage from one body cavity to another or to the skin).
Talk to your doctor if you have severe abdominal pain while taking this medicine.
Your doctor should stop axitinib at least 24 hours before surgery, as it may affect wound healing. Treatment with this medicine should be restarted when the wound is well healed.
Call the emergency service immediately and contact your doctor. This may be a rare neurological side effect known as reversible posterior leukoencephalopathy syndrome.
Your doctor should perform blood tests to monitor your liver function before and during treatment with axitinib.
Axitinib may increase the risk of heart failure events. Your doctor should monitor you for signs or symptoms of heart failure events periodically throughout treatment with axitinib.
Use in children and adolescents
Axitinib is not recommended for people under 18 years of age. This medicine has not been studied in children and adolescents.
Other medicines and Axitinib Teva
Some medicines may affect axitinib or be affected by it. Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines, including those without a prescription, vitamins, and herbal medicines. The medicines listed in this leaflet may not be the only ones that interact with axitinib.
The following medicines may increase the risk of side effects with axitinib:
The following medicines may decrease the effectiveness of axitinib:
Do nottake these medicines during treatment with axitinib. If you are taking any of them, tell your doctor, pharmacist, or nurse. Your doctor may change the dose of these medicines, change the dose of axitinib, or change to another medicine.
Axitinib may increase the side effects associated with theophylline, used to treat asthma or other lung diseases.
Taking Axitinib Teva with food and drinks
Do not take this medicine with grapefruit or grapefruit juice, as it may increase the risk of side effects.
Pregnancy and breastfeeding
Driving and using machines
If you experience dizziness and/or feel tired while taking axitinib, be careful when driving or using machines.
Axitinib Teva contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Axitinib Teva contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially "sodium-free".
Follow exactly the instructions of your doctor for taking this medicine. If you are not sure, talk to your doctor, pharmacist, or nurse.
The recommended dose is 5 mg twice a day. Your doctor may increase or decrease your dose depending on how you tolerate treatment with axitinib.
Swallow the tablets whole with a little water, with or without food. Take the doses of axitinib approximately every 12 hours.
Use in children and adolescents
Axitinib is not recommended for people under 18 years of age. This medicine has not been studied in children and adolescents.
If you take more Axitinib Teva than you should
If you accidentally take more tablets or a higher dose than you need, contact your doctor immediately for advice. If possible, show your doctor the pack or this leaflet. You may need medical attention.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Axitinib Teva
Take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.
If you vomit while taking Axitinib Teva
If you vomit, do not take an additional dose. Take the next dose at the usual time.
If you stop taking Axitinib Teva
If you are not able to take this medicine as your doctor has prescribed, or if you think you no longer need it, contact your doctor immediately.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious. You should contact your doctor immediately if you experience any of the following serious side effects (see also section 2 "What you need to know before you take Axitinib Teva"):
Other side effects with axitinib may include:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Frequency not known: cannot be estimated from the available data
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Store in the original package to protect from moisture. This medicine does not require any special storage temperature.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Axitinib Teva Composition
Axitinib Teva 1 mg: each tablet contains 1 mg of axitinib.
Axitinib Teva 5 mg: each tablet contains 5 mg of axitinib.
Product Appearance and Package Contents
Axitinib Teva 1 mg film-coated tablets are red, round, biconvex, approximately 6 mm in diameter, and engraved with "A7TI" on one side and "1" on the other.
Axitinib Teva 5 mg film-coated tablets are red, oval, biconvex, approximately 15 mm long and 8 mm wide, and engraved with "A7TI" on one side and "5" on the other.
Axitinib Teva is available in blisters or perforated unit-dose blisters (OPA/Al/PVC/Al (Al/Al)) packaged in cardboard boxes.
Each package contains 56, 60, 56 (unit dose) or 120 (unit dose) film-coated tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Teva Pharma, S.L.U.
Anabel Segura 11, Edificio Albatros B, 1st floor.
28108 Alcobendas. Madrid (Spain).
Manufacturer
Synthon Hispania, S.L.
Castelló, 1
08830 Sant Boi de Llobregat (Barcelona)
Spain
or
Synthon BV
Microweg 22
6545 CM Nijmegen
Netherlands
or
Balkanpharma-Dupnitsa AD
3 Samokovsko Shosse Str.
Dupnitsa, 2600, Bulgaria
Date of Last Revision of this Leaflet: May 2024
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
You can access detailed and updated information about this medicinal product by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/XXXXX/P_XXXXX.html.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for AXITINIB TEVA 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.